Skip to content
PharmaKnowl Logo
  • Home
  • About
  • Services
    • Regulatory Affairs Services
    • Pharmacovigilance Services
    • Clinical Trials & Research Services
    • Quality Services
  • Insights
  • Resources
  • Patients
    • Report Side Effects
  • English
    • عربي
    • Deutsch
    • 简体中文
    • Français
    • Italiano
    • 日本語
    • 한국어
    • Español
    • Português
Contact Us

Insights

  1. Home
  2. Insights

Posts in Category: Insights

  • Biosimilars Registration: SFDA Considerations

  • Literature Monitoring-Activity in Saudi PV Systems

    Literature Monitoring Activity in Saudi PV Systems

  • Veterinary Drug Registration in SFDA

  • Economic-Evaluation-Studies-EES-SFDA

    Economic Evaluation Studies (EES) requirments in SFDA

  • SaMD-Registration-in-SFDA-(Software-as-a-Medical-Device)

    SaMD Registration in SFDA (Software as a Medical Device)

  • MDMA Update Process

  • Overview of SFDA Conditional Approval for New Medicines

  • SFDA Drug Pricing Rules in Saudi Arabia

  • CAR-T-Cell-Registration-in-SFDA

    CAR T Cell Registration in SFDA

  • How to develop and submit RMP & RMM to SFDA?

    Understanding RMP & RMMs in SFDA PV Regulation

  • Drug Scientific-Office in Saudi Arabia, what is required and when?

    Scientific Office License Requirements by SFDA

  • How to report medical device cases to SFDA?

    Reporting Medical Device Incidents & Adverse Events to SFDA

Previous12345Next

Subscribe to our Newsletter

Receive the latest regulatory news and insights

Thank you, you are subscribed.
There was an error. Please try again later.
PharmaKnowl logo
  • Services
  • Regulatory Affairs Services
  • Clinical Trials & Research Services
  • Pharmacovigilance Services
  • Quality Services
  • About
  • Insights
  • Resources
  • Contact Us
  • Report Side Effects

© 2014 - 2025 • PharmaKnowl is a registered Trade Mark • Content Rights Reserved • Riyadh, Saudi Arabia

  • Privacy Policy
  • Cookie Policy
  • Terms and Conditions
Page load link
  • Homepage
  • Our Services
    • Regulatory Affairs Services
    • Pharmacovigilance Services
    • Quality Services
  • About
  • Our Blog
  • Contact Us
  • English
    • عربي
    • Deutsch
    • 简体中文
    • Français
    • Italiano
    • 日本語
    • 한국어
    • Español
    • Português

Contact Our Business Support Team

Sunday to Thursday: 9:00 am – 5:00 pm

+966 11 277 7729

+966 11 240 4409

Go to Top